Conferences

16–18 February 2015, San Francisco, CA, USA
Cambridge Healthtech Institute’s 3rd Annual Companion Diagnostics Conference

The field of companion diagnostics is undergoing radical changes with the battery of sequencing tests available and adoption of new clinical trial protocols. The reality is becoming apparent that a new strategy is needed for implementing and commercializing molecularly guided therapies. More personalized therapies are available but significant questions remain as to how to get patients the treatments best suited to their disease. Multi-gene panels are becoming the standard of care in oncology but the practice is far from commonplace. Practical aspects of reimbursement, regulation, patient payment responsibility, commercial launch and drug development will be covered in this comprehensive program detailing the state-of-the-art process for implementing companion diagnostics.

http://www.triconference.com/Companion-Diagnostics-Strategies/

Back to TopTop